Herpes zoster ophthalmicus (HZO) secondary to platelet-rich plasma (PRP) therapy - A case report

Abstract

Androgenetic alopecia (AGA) is a common and benign cause of chronic hair loss that affects both males and females. Platelet-rich plasma (PRP) is a safe and minimally invasive technique with promising outcomes in patients with AGA, alongside other therapeutics use. The currently available data in the literature assures that the rate of side effects is low but includes infection and localized reaction (Stevens and Khetarpal, Feb. 2019) [1]. This article describes a case of herpes zoster ophthalmicus (HZO) following PRP treatment for androgenic alopecia, while shedding light on the importance of respecting the guidelines when injecting PRP therapy to ensure a safe outcome with no complications.

Keywords

• AGA: Androgenetic Alopecia
• PRP: platelet-rich plasma
• HZO: herpes zoster ophthalmicus